CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...

Basel, 05 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) ...

Amber Hill spent 14 years as a medical researcher. She didn’t mind the work, but there was one thing she consistently hated: ...

Learn more about lung cancer clinical trials at MSK. This study was partly supported by the National Institutes of ...

Compass Pathways' latest update reveals extended trial timelines, staff cuts, and financial concerns, raising questions about ...

The path from a scientist’s initial idea to a new medicine that can save lives is a complex and often lengthy process. It ...

Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its ...

Nkarta is working on engineered NK cell therapies for autoimmune diseases and cancer. Click here to find out why I maintain a ...

Real-time index price for S&P 500 Consumer Staples [Sector] (SRCS), along with buy or sell indicators, analysis, charts, ...

Europe has been falling behind on clinical trials over the past decade as pharmaceutical companies shift their focus to the US and Asia in search of speedier solutions, according to a new study. View ...